- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
According to our latest study, the global Oncology Drugs market size was valued at USD 203160 million in 2022 and is forecast to a readjusted size of USD 392310 million by 2029 with a CAGR of 9.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
This report is a detailed and comprehensive analysis for global Oncology Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Celgene, Novartis, Bristol-Myers Squibb and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Market segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Market segment by players, this report covers
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Drugs, with revenue, gross margin and global market share of Oncology Drugs from 2018 to 2023.
Chapter 3, the Oncology Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Drugs.
Chapter 13, to describe Oncology Drugs research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oncology Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Drugs by Type
1.3.1 Overview: Global Oncology Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncology Drugs Consumption Value Market Share by Type in 2022
1.3.3 Chemotherapy
1.3.4 Targeted Therapy
1.3.5 Immunotherapy (Biologic Therapy)
1.3.6 Hormonal Therapy
1.3.7 Others
1.4 Global Oncology Drugs Market by Application
1.4.1 Overview: Global Oncology Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory or Lung Cancer
1.4.7 Others
1.5 Global Oncology Drugs Market Size & Forecast
1.6 Global Oncology Drugs Market Size and Forecast by Region
1.6.1 Global Oncology Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncology Drugs Market Size by Region, (2018-2029)
1.6.3 North America Oncology Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Oncology Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncology Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Oncology Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncology Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology Drugs Product and Solutions
2.1.4 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene Oncology Drugs Product and Solutions
2.2.4 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Celgene Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Oncology Drugs Product and Solutions
2.3.4 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Oncology Drugs Product and Solutions
2.4.4 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Oncology Drugs Product and Solutions
2.5.4 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Oncology Drugs Product and Solutions
2.6.4 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck & Co. Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Oncology Drugs Product and Solutions
2.7.4 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Oncology Drugs Product and Solutions
2.8.4 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Oncology Drugs Product and Solutions
2.9.4 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amgen Recent Developments and Future Plans
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Oncology Drugs Product and Solutions
2.10.4 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly Recent Developments and Future Plans
2.11 AbbVie
2.11.1 AbbVie Details
2.11.2 AbbVie Major Business
2.11.3 AbbVie Oncology Drugs Product and Solutions
2.11.4 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AbbVie Recent Developments and Future Plans
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Oncology Drugs Product and Solutions
2.12.4 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Takeda Recent Developments and Future Plans
2.13 Astellas
2.13.1 Astellas Details
2.13.2 Astellas Major Business
2.13.3 Astellas Oncology Drugs Product and Solutions
2.13.4 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Astellas Recent Developments and Future Plans
2.14 Ipsen
2.14.1 Ipsen Details
2.14.2 Ipsen Major Business
2.14.3 Ipsen Oncology Drugs Product and Solutions
2.14.4 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ipsen Recent Developments and Future Plans
2.15 Sanofi
2.15.1 Sanofi Details
2.15.2 Sanofi Major Business
2.15.3 Sanofi Oncology Drugs Product and Solutions
2.15.4 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sanofi Recent Developments and Future Plans
2.16 Bayer
2.16.1 Bayer Details
2.16.2 Bayer Major Business
2.16.3 Bayer Oncology Drugs Product and Solutions
2.16.4 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Bayer Recent Developments and Future Plans
2.17 Biogen Idec
2.17.1 Biogen Idec Details
2.17.2 Biogen Idec Major Business
2.17.3 Biogen Idec Oncology Drugs Product and Solutions
2.17.4 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Biogen Idec Recent Developments and Future Plans
2.18 Teva
2.18.1 Teva Details
2.18.2 Teva Major Business
2.18.3 Teva Oncology Drugs Product and Solutions
2.18.4 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Teva Recent Developments and Future Plans
2.19 Otsuka
2.19.1 Otsuka Details
2.19.2 Otsuka Major Business
2.19.3 Otsuka Oncology Drugs Product and Solutions
2.19.4 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Otsuka Recent Developments and Future Plans
2.20 Eisai
2.20.1 Eisai Details
2.20.2 Eisai Major Business
2.20.3 Eisai Oncology Drugs Product and Solutions
2.20.4 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Eisai Recent Developments and Future Plans
2.21 Merck KGaA
2.21.1 Merck KGaA Details
2.21.2 Merck KGaA Major Business
2.21.3 Merck KGaA Oncology Drugs Product and Solutions
2.21.4 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Merck KGaA Recent Developments and Future Plans
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Oncology Drugs Product and Solutions
2.22.4 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Gilead Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncology Drugs by Company Revenue
3.2.2 Top 3 Oncology Drugs Players Market Share in 2022
3.2.3 Top 6 Oncology Drugs Players Market Share in 2022
3.3 Oncology Drugs Market: Overall Company Footprint Analysis
3.3.1 Oncology Drugs Market: Region Footprint
3.3.2 Oncology Drugs Market: Company Product Type Footprint
3.3.3 Oncology Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oncology Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncology Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Oncology Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncology Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Oncology Drugs Consumption Value by Type (2018-2029)
6.2 North America Oncology Drugs Consumption Value by Application (2018-2029)
6.3 North America Oncology Drugs Market Size by Country
6.3.1 North America Oncology Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Oncology Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Oncology Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncology Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Oncology Drugs Consumption Value by Type (2018-2029)
7.2 Europe Oncology Drugs Consumption Value by Application (2018-2029)
7.3 Europe Oncology Drugs Market Size by Country
7.3.1 Europe Oncology Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Oncology Drugs Market Size and Forecast (2018-2029)
7.3.3 France Oncology Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncology Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Oncology Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Oncology Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncology Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncology Drugs Market Size by Region
8.3.1 Asia-Pacific Oncology Drugs Consumption Value by Region (2018-2029)
8.3.2 China Oncology Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Oncology Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncology Drugs Market Size and Forecast (2018-2029)
8.3.5 India Oncology Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncology Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Oncology Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Oncology Drugs Consumption Value by Type (2018-2029)
9.2 South America Oncology Drugs Consumption Value by Application (2018-2029)
9.3 South America Oncology Drugs Market Size by Country
9.3.1 South America Oncology Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncology Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncology Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncology Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncology Drugs Market Size by Country
10.3.1 Middle East & Africa Oncology Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncology Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncology Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Oncology Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Oncology Drugs Market Drivers
11.2 Oncology Drugs Market Restraints
11.3 Oncology Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Oncology Drugs Industry Chain
12.2 Oncology Drugs Upstream Analysis
12.3 Oncology Drugs Midstream Analysis
12.4 Oncology Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Oncology Drugs Product and Solutions
Table 8. Roche Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Celgene Company Information, Head Office, and Major Competitors
Table 11. Celgene Major Business
Table 12. Celgene Oncology Drugs Product and Solutions
Table 13. Celgene Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Celgene Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Oncology Drugs Product and Solutions
Table 18. Novartis Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb Oncology Drugs Product and Solutions
Table 23. Bristol-Myers Squibb Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 26. Johnson & Johnson Major Business
Table 27. Johnson & Johnson Oncology Drugs Product and Solutions
Table 28. Johnson & Johnson Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Johnson & Johnson Recent Developments and Future Plans
Table 30. Merck & Co. Company Information, Head Office, and Major Competitors
Table 31. Merck & Co. Major Business
Table 32. Merck & Co. Oncology Drugs Product and Solutions
Table 33. Merck & Co. Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck & Co. Recent Developments and Future Plans
Table 35. AstraZeneca Company Information, Head Office, and Major Competitors
Table 36. AstraZeneca Major Business
Table 37. AstraZeneca Oncology Drugs Product and Solutions
Table 38. AstraZeneca Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. AstraZeneca Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Oncology Drugs Product and Solutions
Table 43. Pfizer Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Amgen Company Information, Head Office, and Major Competitors
Table 46. Amgen Major Business
Table 47. Amgen Oncology Drugs Product and Solutions
Table 48. Amgen Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Amgen Recent Developments and Future Plans
Table 50. Eli Lilly Company Information, Head Office, and Major Competitors
Table 51. Eli Lilly Major Business
Table 52. Eli Lilly Oncology Drugs Product and Solutions
Table 53. Eli Lilly Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eli Lilly Recent Developments and Future Plans
Table 55. AbbVie Company Information, Head Office, and Major Competitors
Table 56. AbbVie Major Business
Table 57. AbbVie Oncology Drugs Product and Solutions
Table 58. AbbVie Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AbbVie Recent Developments and Future Plans
Table 60. Takeda Company Information, Head Office, and Major Competitors
Table 61. Takeda Major Business
Table 62. Takeda Oncology Drugs Product and Solutions
Table 63. Takeda Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Takeda Recent Developments and Future Plans
Table 65. Astellas Company Information, Head Office, and Major Competitors
Table 66. Astellas Major Business
Table 67. Astellas Oncology Drugs Product and Solutions
Table 68. Astellas Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Astellas Recent Developments and Future Plans
Table 70. Ipsen Company Information, Head Office, and Major Competitors
Table 71. Ipsen Major Business
Table 72. Ipsen Oncology Drugs Product and Solutions
Table 73. Ipsen Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Ipsen Recent Developments and Future Plans
Table 75. Sanofi Company Information, Head Office, and Major Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Oncology Drugs Product and Solutions
Table 78. Sanofi Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Sanofi Recent Developments and Future Plans
Table 80. Bayer Company Information, Head Office, and Major Competitors
Table 81. Bayer Major Business
Table 82. Bayer Oncology Drugs Product and Solutions
Table 83. Bayer Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Bayer Recent Developments and Future Plans
Table 85. Biogen Idec Company Information, Head Office, and Major Competitors
Table 86. Biogen Idec Major Business
Table 87. Biogen Idec Oncology Drugs Product and Solutions
Table 88. Biogen Idec Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Biogen Idec Recent Developments and Future Plans
Table 90. Teva Company Information, Head Office, and Major Competitors
Table 91. Teva Major Business
Table 92. Teva Oncology Drugs Product and Solutions
Table 93. Teva Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Teva Recent Developments and Future Plans
Table 95. Otsuka Company Information, Head Office, and Major Competitors
Table 96. Otsuka Major Business
Table 97. Otsuka Oncology Drugs Product and Solutions
Table 98. Otsuka Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Otsuka Recent Developments and Future Plans
Table 100. Eisai Company Information, Head Office, and Major Competitors
Table 101. Eisai Major Business
Table 102. Eisai Oncology Drugs Product and Solutions
Table 103. Eisai Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Eisai Recent Developments and Future Plans
Table 105. Merck KGaA Company Information, Head Office, and Major Competitors
Table 106. Merck KGaA Major Business
Table 107. Merck KGaA Oncology Drugs Product and Solutions
Table 108. Merck KGaA Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Merck KGaA Recent Developments and Future Plans
Table 110. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 111. Gilead Sciences Major Business
Table 112. Gilead Sciences Oncology Drugs Product and Solutions
Table 113. Gilead Sciences Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Gilead Sciences Recent Developments and Future Plans
Table 115. Global Oncology Drugs Revenue (USD Million) by Players (2018-2023)
Table 116. Global Oncology Drugs Revenue Share by Players (2018-2023)
Table 117. Breakdown of Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Oncology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 119. Head Office of Key Oncology Drugs Players
Table 120. Oncology Drugs Market: Company Product Type Footprint
Table 121. Oncology Drugs Market: Company Product Application Footprint
Table 122. Oncology Drugs New Market Entrants and Barriers to Market Entry
Table 123. Oncology Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Oncology Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 125. Global Oncology Drugs Consumption Value Share by Type (2018-2023)
Table 126. Global Oncology Drugs Consumption Value Forecast by Type (2024-2029)
Table 127. Global Oncology Drugs Consumption Value by Application (2018-2023)
Table 128. Global Oncology Drugs Consumption Value Forecast by Application (2024-2029)
Table 129. North America Oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 130. North America Oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 131. North America Oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 132. North America Oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 133. North America Oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 134. North America Oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 135. Europe Oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 136. Europe Oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 137. Europe Oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 138. Europe Oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 139. Europe Oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 142. Asia-Pacific Oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 143. Asia-Pacific Oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 144. Asia-Pacific Oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 145. Asia-Pacific Oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 146. Asia-Pacific Oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 147. South America Oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 148. South America Oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 149. South America Oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 150. South America Oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 151. South America Oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 152. South America Oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 153. Middle East & Africa Oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 154. Middle East & Africa Oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 155. Middle East & Africa Oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 156. Middle East & Africa Oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 157. Middle East & Africa Oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 158. Middle East & Africa Oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 159. Oncology Drugs Raw Material
Table 160. Key Suppliers of Oncology Drugs Raw Materials
List of Figures
Figure 1. Oncology Drugs Picture
Figure 2. Global Oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Drugs Consumption Value Market Share by Type in 2022
Figure 4. Chemotherapy
Figure 5. Targeted Therapy
Figure 6. Immunotherapy (Biologic Therapy)
Figure 7. Hormonal Therapy
Figure 8. Others
Figure 9. Global Oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Oncology Drugs Consumption Value Market Share by Application in 2022
Figure 11. Blood Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Gastrointestinal Cancer Picture
Figure 14. Prostate Cancer Picture
Figure 15. Respiratory or Lung Cancer Picture
Figure 16. Others Picture
Figure 17. Global Oncology Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Oncology Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market Oncology Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global Oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 21. Global Oncology Drugs Consumption Value Market Share by Region in 2022
Figure 22. North America Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Oncology Drugs Revenue Share by Players in 2022
Figure 28. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players Oncology Drugs Market Share in 2022
Figure 30. Global Top 6 Players Oncology Drugs Market Share in 2022
Figure 31. Global Oncology Drugs Consumption Value Share by Type (2018-2023)
Figure 32. Global Oncology Drugs Market Share Forecast by Type (2024-2029)
Figure 33. Global Oncology Drugs Consumption Value Share by Application (2018-2023)
Figure 34. Global Oncology Drugs Market Share Forecast by Application (2024-2029)
Figure 35. North America Oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 36. North America Oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. North America Oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe Oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe Oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe Oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. France Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 52. China Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. India Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. South America Oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. South America Oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. South America Oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa Oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa Oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa Oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE Oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 69. Oncology Drugs Market Drivers
Figure 70. Oncology Drugs Market Restraints
Figure 71. Oncology Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Oncology Drugs in 2022
Figure 74. Manufacturing Process Analysis of Oncology Drugs
Figure 75. Oncology Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
